Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

qps logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation

 

Drug Life Cycle Stages:

Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)

Main Service Areas:
Bioanalytical, Clinical, Preclinical

Services & Capabilities:
Bioanalytical: small molecules, peptides, large molecules, antibody drug conjugates, oligonucleotides,
elements & elemental tags, biomarkers; Clinical: study design & protocol writing, clinical
conduct, clinical project management, site management & monitoring, data management, biostatistics, CDI SC-compliant clinical study reports; Preclinical: IND program management, ADME, neuropharmacology, general toxicology, reproductive toxicology

Therapeutic Areas:
CN S disorders/neurodegenerative diseases, asthma/COPD , immunology/autoimmune  disease/rheumatoid arthritis, inflammatory diseases/immune status/cell response, infectious disease, dermatology, oncology, allergy, anemia, bone disease/metabolism, cardiovascular disease,  diabetes/obesity/lipid metabolism/carbohydrate metabolism, female healthcare/gynecological, endocrinology/reproductive endocrinology, gastrointestinal disorders, hemostasis

Dr. Ben Chien

CEO

“I am pleased and proud of QPS employees for consistently delivering the highest grade of discovery, preclinical, and clinical drug development services. Their exceptional performance and dedication are underscored by this CRO Leadership Award. Through continual enhancements in our capacities and resources, we stand tall in our commitment to deliver superior science, quality, skilled performance, and trusted service to our valued customers. We are well-positioned to succeed in realizing our corporate vision: to become a global leader in contract research.”